2015 New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape

2015 New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape

Category : Diagnostic and Biotech
Published On : June  2015
Pages : 450



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

2015 New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the POC coagulation market segment, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for coagulation procedures by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Operating/Recovery Suites      
- ICUs/CCUs 
- Cancer Clinics        
- Ambulatory Care Centers        
- Surgery Centers 
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Coagulation Tests

Activated Clotting Time (ACT) (1) , Activated Protein C Resistance,
Activated PTT (APTT) , Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,
Factor Ixa, Factor X (Stuart Factor) , Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT) , Reptilase Time, Thrombin Time,
Von Willebrand's Factor Fav/Ag, and others.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies
  and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially
  significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product
  portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott
   - ADI/American Diagnostica
   - Axis-Shield
   - Alere/Biosite/Inverness
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Bio/Data
   - Chrono-Log
   - Corgenix
   - Diagnostica Stago/Trinity Biotech
   - Grifols
   - Helena Laboratories
   - Hyphen BioMed
   - Instrumentation Laboratory
   - International Technidyne/Nexus DX
   - Roche
   - Siemens
   - Sienco
   - Sysmex
   - ThermoFisher
   - Zycare/Alere

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.

Contains 450 pages and 53 tables

image
Can't read the image ? refresh here.


Enquiry Before Buy
image
Can´t read the image ? refresh here.